These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 20011209)

  • 1. Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.
    Ntimbane T; Comte B; Mailhot G; Berthiaume Y; Poitout V; Prentki M; Rabasa-Lhoret R; Levy E
    Clin Biochem Rev; 2009 Nov; 30(4):153-77. PubMed ID: 20011209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet-intrinsic effects of CFTR mutation.
    Koivula FNM; McClenaghan NH; Harper AGS; Kelly C
    Diabetologia; 2016 Jul; 59(7):1350-1355. PubMed ID: 27033560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes.
    Hasan S; Khan MS; Lansang MC
    J Clin Transl Endocrinol; 2022 Sep; 29():100301. PubMed ID: 35746945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFTR silencing in pancreatic β-cells reveals a functional impact on glucose-stimulated insulin secretion and oxidative stress response.
    Ntimbane T; Mailhot G; Spahis S; Rabasa-Lhoret R; Kleme ML; Melloul D; Brochiero E; Berthiaume Y; Levy E
    Am J Physiol Endocrinol Metab; 2016 Feb; 310(3):E200-12. PubMed ID: 26625901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic Fibrosis-Related Diabetes.
    Kayani K; Mohammed R; Mohiaddin H
    Front Endocrinol (Lausanne); 2018; 9():20. PubMed ID: 29515516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors.
    Iafusco F; Maione G; Rosanio FM; Mozzillo E; Franzese A; Tinto N
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33810109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of the "NADPH oxidases" (NOX/DUOX) family in cystic fibrosis.
    Pongnimitprasert N; El-Benna J; Foglietti MJ; Gougerot-Pocidalo MA; Bernard M; Braut-Boucher F
    Ann Biol Clin (Paris); 2008; 66(6):621-9. PubMed ID: 19091660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis-related oxidative stress and intestinal lipid disorders.
    Kleme ML; Levy E
    Antioxid Redox Signal; 2015 Mar; 22(7):614-31. PubMed ID: 25611180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
    Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
    Diabetes; 2023 Jun; 72(6):677-689. PubMed ID: 37125945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
    Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
    Diabetes Care; 2023 Jun; 46(6):1112-1123. PubMed ID: 37125948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics.
    Kunzelmann K; Mall M
    Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (
    Meoli A; Fainardi V; Deolmi M; Chiopris G; Marinelli F; Caminiti C; Esposito S; Pisi G
    Pharmaceuticals (Basel); 2021 Sep; 14(9):. PubMed ID: 34577628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CFTR Deficiency Affects Glucose Homeostasis via Regulating GLUT4 Plasma Membrane Transportation.
    Gu J; Zhang W; Wu L; Gu Y
    Front Cell Dev Biol; 2021; 9():630654. PubMed ID: 33659254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic Fibrosis-Related Diabetes: Pathophysiology and Therapeutic Challenges.
    Kelsey R; Manderson Koivula FN; McClenaghan NH; Kelly C
    Clin Med Insights Endocrinol Diabetes; 2019; 12():1179551419851770. PubMed ID: 31191067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CFTR Correctors and Antioxidants Partially Normalize Lipid Imbalance but not Abnormal Basal Inflammatory Cytokine Profile in CF Bronchial Epithelial Cells.
    Veltman M; De Sanctis JB; Stolarczyk M; Klymiuk N; Bähr A; Brouwer RW; Oole E; Shah J; Ozdian T; Liao J; Martini C; Radzioch D; Hanrahan JW; Scholte BJ
    Front Physiol; 2021; 12():619442. PubMed ID: 33613309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted CFTR gene disruption with zinc-finger nucleases in human intestinal epithelial cells induces oxidative stress and inflammation.
    Kleme ML; Sané AT; Garofalo C; Levy E
    Int J Biochem Cell Biol; 2016 May; 74():84-94. PubMed ID: 26923293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages.
    Gillan JL; Davidson DJ; Gray RD
    Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33303535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and antioxidant therapy in cystic fibrosis.
    Galli F; Battistoni A; Gambari R; Pompella A; Bragonzi A; Pilolli F; Iuliano L; Piroddi M; Dechecchi MC; Cabrini G;
    Biochim Biophys Acta; 2012 May; 1822(5):690-713. PubMed ID: 22226887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSH monoethyl ester rescues mitochondrial defects in cystic fibrosis models.
    Kelly-Aubert M; Trudel S; Fritsch J; Nguyen-Khoa T; Baudouin-Legros M; Moriceau S; Jeanson L; Djouadi F; Matar C; Conti M; Ollero M; Brouillard F; Edelman A
    Hum Mol Genet; 2011 Jul; 20(14):2745-59. PubMed ID: 21518732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Mirc1/Mir17-92 cluster expression negatively regulates autophagy and CFTR (cystic fibrosis transmembrane conductance regulator) function in CF macrophages.
    Tazi MF; Dakhlallah DA; Caution K; Gerber MM; Chang SW; Khalil H; Kopp BT; Ahmed AE; Krause K; Davis I; Marsh C; Lovett-Racke AE; Schlesinger LS; Cormet-Boyaka E; Amer AO
    Autophagy; 2016 Nov; 12(11):2026-2037. PubMed ID: 27541364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.